Rybelsus and Weight Loss: What You Should Know
Rybelsus was the first GLP-1 pill, and many people searching for a weight-loss pill land on it. For weight loss, two newer tablets are now approved and are what BeLite prescribes: the Wegovy pill and Foundayo.
What Rybelsus is
Rybelsus is oral semaglutide, approved in 2019 to improve blood sugar in adults with type 2 diabetes, in 3, 7, and 14 mg tablets. It is the same molecule as Wegovy and Ozempic, but at doses chosen for glucose control. Modest weight loss occurs, but Rybelsus is not approved for weight management and its doses are well below what weight loss requires.
The weight-loss pills
- Wegovy pill — oral semaglutide at 25 mg, approved December 2025. Average weight loss of 13.6% at 64 weeks (16.6% among those who stayed on treatment), matching the Wegovy injection. Same morning routine as Rybelsus: empty stomach, no more than 4 ounces of water, 30-minute wait.
- Foundayo (orforglipron) — a different GLP-1 molecule, approved April 2026. Average weight loss of about 12.4% at 72 weeks on the highest dose in patients who stayed on treatment. No food or water rules; take it any time.
If you are already on Rybelsus for diabetes and want to lose weight, your BeLite provider can discuss a switch to one of these in coordination with the doctor who manages your diabetes — the medications are not taken together.
If you have type 2 diabetes
BeLite treats weight, not diabetes. Your primary care physician or endocrinologist continues to manage your diabetes and any Rybelsus prescription, and we coordinate with them, including on insulin or sulfonylurea adjustments as your weight comes down.
Cautions shared by all GLP-1 pills
Nausea, diarrhea, constipation, and vomiting are the common side effects. None of these medications is used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, in pregnancy, or together with another GLP-1 medication.
Ready to find out which medication fits you? BeLite Medical Center’s medical providers have been prescribing weight-loss medication in Fairfax since 1995. Schedule online 24/7 at belitecom.simplybook.me or call or text (703) 359-9200. The consultation is free for new patients; the $150 new-patient fee applies only if you enroll.
Disclaimer
This page is general information, not medical advice. Whether any medication is right for you depends on your health history and can only be decided by a licensed medical provider after an evaluation. Prescription medications are prescribed only after an in-person visit at BeLite Medical Center, 3923 Blenheim Blvd, Suite 61A, Fairfax, VA 22030.
Sources (verified September 7, 2026)
- Wharton S et al. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity (OASIS 4). N Engl J Med. 2025;393(11):1077-1087. https://pubmed.ncbi.nlm.nih.gov/40934115/
- Wharton S et al. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment (ATTAIN-1). N Engl J Med. 2025;393(18):1796-1806. https://pubmed.ncbi.nlm.nih.gov/40960239/
Medications

Wegovy Pill
Oral semaglutide approved for weight loss.

Foundayo
A GLP-1 pill with no food or water restrictions.

Semaglutide
How Rybelsus, Ozempic, and Wegovy relate.































